Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Forward Pharma A/SEntasis TherapeuticsAdvaxisHoth TherapeuticsRegeneRx Biopharmaceuticals
Price Information
Current Price$6.16$2.94$0.56$2.58$0.35
52 Week RangeN/ABuyN/AHoldN/A
Beat the Market™ Rank
Overall Score0.
Analysis Score0.
Community Score2.
Dividend Score0.
Ownership Score0.
Earnings & Valuation Score0.
Analyst Ratings
Consensus RecommendationN/ABuyN/AHoldN/A
Consensus Price TargetN/A$6.60N/A$10.00N/A
% Upside from Price TargetN/A124.49% upsideN/A287.60% upsideN/A
Trade Information
Market Cap$41.49 million$40.77 million$34.44 million$33.82 million$40.03 million
Average Volume157,696315,2061,009,227446,39768,513
Sales & Book Value
Annual Revenue$1.25 billion$7 million$20.88 millionN/A$80,000.00
Price / Sales0.036.141.65N/A583.47
Price / CashN/AN/AN/AN/AN/A
Book Value$11.42 per share$3.17 per share$2.30 per share$0.24 per share($0.02) per share
Price / Book0.540.930.24N/A-17.49
Net Income$-4,220,000.00$-43,850,000.00$-16,610,000.00$-7,700,000.00$-1,400,000.00
Trailing P/E Ratio0.00N/AN/A0.000.00
Forward P/E RatioN/A
Net MarginsN/AN/A-13,144.62%N/A-1,910.16%
Return on Equity (ROE)N/A-101.15%-82.46%-221.49%N/A
Return on Assets (ROA)N/A-85.72%-69.06%-205.42%-161.30%
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt-to-Equity RatioN/A0.04%0.16%N/AN/A
Current Ratio131.15%5.67%7.52%9.36%2.33%
Quick Ratio131.15%5.67%7.52%9.36%2.33%
Ownership Information
Institutional Ownership Percentage19.39%56.90%11.50%0.28%0.19%
Insider Ownership PercentageN/A15.40%0.26%17.27%11.60%
Shares Outstanding6.79 million14.61 million61.61 million13.42 million133.44 million
Next Earnings DateN/A8/10/2020 (Estimated)9/14/2020 (Estimated)8/12/2020 (Estimated)8/12/2020 (Estimated)
OptionableNot OptionableNot OptionableOptionableNot OptionableNot Optionable

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.